Results 121 to 130 of about 18,054 (205)

The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1. [PDF]

open access: yesLeukemia
Shoumariyeh K   +14 more
europepmc   +1 more source

Targeted triplet therapies incorporating FLT3 or IDH inhibitors: ready for prime time? [PDF]

open access: yesHematology Am Soc Hematol Educ Program
Atluri H, Abaza Y, Altman JK.
europepmc   +1 more source

A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis. [PDF]

open access: yesTher Adv Hematol
Sawa M   +17 more
europepmc   +1 more source

Hsp70 Peptides Induce TREM-1-Dependent and TREM-1-Independent Activation of Cytotoxic Lymphocytes. [PDF]

open access: yesInt J Mol Sci
Yurkina DM   +8 more
europepmc   +1 more source

Survival Outcome of AML Patients with and without TKD Mutations

open access: yesAsian Pacific Journal of Cancer Prevention, 2015
Sadaf, Shahab   +9 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy